1. European Medicines Agency (2015) Assessment report. Procedure No. EMEA/H/C/003770/0000, 26 March 2015, EMA/238334/2015
2. Indian Pharmacopoeia (2014) Vol II. Government of India, Ministry of Health and Family Welfare, Indian Pharmacopoeia Commission, Ghaziabad, pp 2186–2187
3. British Pharmacopoeia (2008) Vol II. The Stationary Office on behalf of Medicines and Health Care Products Regulatory Agency (MHRA), London, pp 1410–1411
4. United States Pharmacopeia 34, National Formulary 29 (2011) Vol III. United States Pharmacopeial Convention, Rockville, MD, pp 3442
5. www.accessdata.fda.gov/drugsatfda_docs/nda/2015/206111Orig1s000TOC.cfm. Visited on 07 Dec 2017